Our work suggests that Pellino-1 is a key component of the immune response to NTHi in the airway and that therapeutically targeting Pellino-1 may enhance immunity in patients with COPD who are at risk of infection induced exacerbations. The gene discussed is PELI1; the disease is chronic obstructive pulmonary disease.